This study intended to explore the correlation of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma (NPC). From January 2008 to January 2011, 123 NPC patients and 59 patients with chronic rhinitis were enrolled in this study. Fresh NPC and normal nasopharynx tissue specimens were obtained during surgery. Immunohistochemistry (IHC) was adopted to determine the positive expressions of the c-Jun and Egr-1 proteins. A 5-year clinical follow-up was conducted on all NPC patients. The Kaplan-Meier survival curve and Cox regression model were used for survival analysis. Compared with normal nasopharynx tissues, c-Jun expression was up-regulated but Egr-1 expression was down-regulated in NPC tissues. NPC patients with stage T3-T4 or stage III-IV had higher positive rates of c-Jun expression than those with stage T1-T2 or stage I-II. However, the positive rates of Egr-1 expression was higher in patients with stage T1-T2 or stage III-IV than those with stage T3-T4 or stage I-II. The survival rate of NPC patients with high c-Jun expression was lower than those with low/negative c-Jun expression, while the survival rate of NPC patients with high Egr-1 expression was higher than those with low/negative Egr-1 expression. The Cox regression analysis revealed that stage T3-T4, high c-Jun expression, and low Egr-1 expression were risk factors for poor prognosis of NPC patients. In conclusion, our study suggests that the c-Jun and Egr-1 proteins can serve as novel potential biomarkers for the early diagnosis and prognosis prediction of NPC.
TangX, ZhouY, LiW, TangQ, ChenR, ZhuJ, FengZ, T cells expressing a lmp1-specific chimeric antigen receptor mediate antitumor effects against lmp1-positive nasopharyngeal carcinoma cells in vitro and in vivo, J Biomed Res28 (2014), 468-475.
2.
YuMC, YuanJM, Epidemiology of nasopharyngeal carcinoma, Semin Cancer Biol12 (2002), 421-429.
3.
SunR, WangX, LiX, Correlation analysis of nasopharyngeal carcinoma tnm staging with serum ea iga and vca iga in ebv and vegf-c and -d, Med Sci Monit21 (2015), 2105-2109.
ChanAT, FelipE, GroupEGW, Nasopharyngeal cancer: Esmo clinical recommendations for diagnosis, treatment and follow-up, Ann Oncol20 Suppl 4 (2009), 123-125.
6.
SuarezC, RodrigoJP, RinaldoA, LangendijkJA, ShahaAR, FerlitoA, Current treatment options for recurrent nasopharyngeal cancer, Eur Arch Otorhinolaryngol267 (2010), 1811-1824.
7.
LohoffM, GiaisiM, KohlerR, CasperB, KrammerPH, Li-WeberM, Early growth response protein-1 (egr-1) is preferentially expressed in t helper type 2 (th2) cells and is involved in acute transcription of the th2 cytokine interleukin-4, J Biol Chem285 (2010), 1643-1652.
8.
MaeharaK, Oh-HashiK, IsobeKI, Early growth-responsive-1-dependent manganese superoxide dismutase gene transcription mediated by platelet-derived growth factor, FASEB J15 (2001), 2025-2026.
9.
AkuzawaN, KurabayashiM, OhyamaY, AraiM, NagaiR, Zinc finger transcription factor egr-1 activates flt-1 gene expression in thp-1 cells on induction for macrophage differentiation, Arterioscler Thromb Vasc Biol20 (2000), 377-384.
10.
XiaJ, XiaK, FengY, TangA, TangY, WuL, LiangD, CaiF, PanQ, LongZ, DaiH, ZhangY, ZhaoS, ChenZ, The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma xenographs, J Radiat Res45 (2004), 281-289.
11.
LinG, LinMC, LinS, YaoH, YuS, YiW, XuG, NgSS, ChenS, YuJ, WangX, YangB, Early growth response protein-1 promoter-mediated synergistic antitumor effect of htertc27 gene therapy and 5-flurorouracil on nasopharyngeal carcinoma, Cancer Biother Radiopharm27 (2012), 434-441.
12.
ZhaoM, LuoR, LiuY, GaoL, FuZ, FuQ, LuoX, ChenY, DengX, LiangZ, LiX, ChengC, LiuZ, FangW, Mir-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a foxo1-modulated positive feedback loop with mtor-p-pi3k/akt-c-jun, Nat Commun7 (2016), 11309.
13.
SchettlerV, VolkerK, SchulzEG, WielandE, Impact of lipid apheresis on egr-1, c-jun, c-fos, and hsp70 gene expression in white blood cells, Ther Apher Dial15 (2011), 105-112.
14.
YuX, ZhenY, YangH, WangH, ZhouY, WangE, MarincolaFM, MaiC, ChenY, WeiH, SongY, LyuX, YeY, CaiL, WuQ, ZhaoM, HuaS, FuQ, ZhangY, YaoK, LiuZ, LiX, FangW, Loss of connective tissue growth factor as an unfavorable prognosis factor activates mir-18b by pi3k/akt/c-jun and c-myc and promotes cell growth in nasopharyngeal carcinoma, Cell Death Dis4 (2013), e634.
15.
SongQ, WangG, ChuY, ZhouL, JiangM, HeQ, LiuM, QinJ, HuJ, Tnf-alpha up-regulates cellular inhibitor of apoptosis protein 2 (c-iap2) via c-jun n-terminal kinase (jnk) pathway in nasopharyngeal carcinoma, Int Immunopharmacol16 (2013), 148-153.
16.
SasakiT, New guidelines to evaluate the response to treatment ``recist'', Gan To Kagaku Ryoho27 (2000), 2179-2184.
17.
FromowitzFB, ViolaMV, ChaoS, OravezS, MishrikiY, FinkelG, GrimsonR, LundyJ, Ras p21 expression in the progression of breast cancer, Hum Pathol18 (1987), 1268-1275.
DakerM, AhmadM, KhooAS, Quercetin-induced inhibition and synergistic activity with cisplatin - a chemotherapeutic strategy for nasopharyngeal carcinoma cells, Cancer Cell Int12 (2012), 34.
21.
ChanKC, ChanLS, IpJC, LoC, YipTT, NganRK, WongRN, LoKW, NgWT, LeeAW, TsaoGS, KahnM, LungML, MakNK, Therapeutic targeting of cbp/beta-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of ebv-positive nasopharyngeal carcinoma cells with cisplatin, Sci Rep5 (2015), 9979.
22.
LeungTW, TungSY, SzeWK, WongFC, YuenKK, LuiCM, LoSH, NgTY, OSK, Treatment results of 1070 patients with nasopharyngeal carcinoma: An analysis of survival and failure patterns, Head Neck27 (2005), 555-565.
23.
HuangCC, WangJM, KikkawaU, MukaiH, ShenMR, MoritaI, ChenBK, ChangWC, Calcineurin-mediated dephosphorylation of c-jun ser-243 is required for c-jun protein stability and cell transformation, Oncogene27 (2008), 2422-2429.
24.
GeeJM, BarrosoAF, EllisIO, RobertsonJF, NicholsonRI, Biological and clinical associations of c-jun activation in human breast cancer, Int J Cancer89 (2000), 177-186.
25.
SumimotoH, ImabayashiF, IwataT, KawakamiY, The braf-mapk signaling pathway is essential for cancer-immune evasion in human melanoma cells, J Exp Med203 (2006), 1651-1656.
26.
ChenBK, HuangCC, ChangWC, ChenYJ, KikkawaU, NakahamaK, MoritaI, ChangWC, Pp2b-mediated dephosphorylation of c-jun c terminus regulates phorbol ester-induced c-jun/sp1 interaction in a431 cells, Mol Biol Cell18 (2007), 1118-1127.
27.
EdwardsJ, KrishnaNS, MukherjeeR, BartlettJM, The role of c-jun and c-fos expression in androgen-independent prostate cancer, J Pathol204 (2004), 153-158.
28.
VleugelMM, GreijerAE, BosR, van der WallE, van DiestPJ, C-jun activation is associated with proliferation and angiogenesis in invasive breast cancer, Hum Pathol37 (2006), 668-674.
MahalingamD, NatoniA, KeaneM, SamaliA, SzegezdiE, Early growth response-1 is a regulator of dr5-induced apoptosis in colon cancer cells, Br J Cancer102 (2010), 754-764.
31.
HannSS, TangQ, ZhengF, ZhaoS, ChenJ, WangZ, Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via egr-1 represents a new approach for inhibition of lung cancer cell growth, Mol Cancer13 (2014), 149.
32.
KimYJ, GoH, WuHG, JeonYK, ParkSW, LeeSH, Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy, Head Neck33 (2011), 1458-1466.
33.
LeeSH, BahnJH, ChoiCK, WhitlockNC, EnglishAE, SafeS, BaekSJ, Ese-1/egr-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells, Mol Cancer Ther7 (2008), 3739-3750.
34.
MyungDS, ParkYL, KimN, ChungCY, ParkHC, KimJS, ChoSB, LeeWS, LeeJH, JooYE, Expression of early growth response-1 in colorectal cancer and its relation to tumor cell proliferation and apoptosis, Oncol Rep31 (2014), 788-794.
35.
MaY, ChengQ, RenZ, XuL, ZhaoY, SunJ, HuS, XiaoW, Induction of igf-1r expression by egr-1 facilitates the growth of prostate cancer cells, Cancer Lett317 (2012), 150-156.
36.
ZhangYL, LiLZ, ChenXG, LiaoZG, WuMY, WuJW, Expression of c-jun mrna in brain stem following moderate lateral fluid percussion brain injury in rats, Zhongguo Ying Yong Sheng Li Xue Za Zhi17 (2001), 337-340.
37.
TianJ, LiZ, HanY, JiangT, SongX, JiangG, The progress of early growth response factor 1 and leukemia, Intractable Rare Dis Res5 (2016), 76-82.
38.
WuMY, LiangYR, WuXY, ZhuangCX, Relationship between egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions, World J Gastroenterol8 (2002), 971-975.
